<i id='4622C49B1F'><strike id='4622C49B1F'><tt id='4622C49B1F'><pre id='4622C49B1F'></pre></tt></strike></i> 
WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.
In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.
advertisement
“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
Continuity nursing helped my family in our darkest PICU moments 
Zyn nicotine pouches become unlikely player in latest culture war 
Guidelines to prevent youth baseball injuries need more muscle 
Merck, Johnson & Johnson CEOs will testify on high drug prices 
FDA approval of Sarepta Duchenne genetic therapy gives me hope 
Drug companies' payments and gifts affect physicians' prescribing 
In Memoriam: Notable people who died in 2023 
Reconstructing family trees of blood cells may help predict disease 
23andMe had bad news about my health. I wish a person had delivered it 
Biogen walks away from Aduhelm, years after polarizing approval 
DIEP, the 'gold standard' of breast reconstruction, is under threat 
How generative AI ratchets up security threats for health systems 
Wildfire smoke exposes gaps in outdoor worker protections 
Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic 
What does generative AI mean for health care? We asked experts 
